Tag: Drug Approvals
FDA Approves First Biosimilar Drug in U.S.
Zarxio is highly similar to long-sanctioned cancer drug
FDA: Opdivo Approval Expanded to Include Lung Cancer
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
FDA Approves New Combination Antibiotic Avycaz
Combination drug sanctioned for abdominal, urinary tract infections
FDA Approves Farydak for Multiple Myeloma
Drug is sanctioned for people who have received at least two prior standard therapies
FDA: New Device Treats Superficial Varicose Veins
Seals the affected superficial veins using an adhesive agent
FDA Permits Marketing of Device for Female Fecal Incontinence
Use of Eclipse System led to 50 percent decrease in episodes
FDA Approves Lenvima for Type of Thyroid Cancer
To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy
FDA OKs Device to Help Prevent Procedure-Related Stroke
Transcarotid system designed to help prevent stroke during stent and angioplasty procedures
FDA Expands Approval of Lucentis for Diabetic Retinopathy
To treat diabetic retinopathy in patients with diabetic macular edema
FDA Approves Ibrance to Treat Advanced Breast Cancer
For postmenopausal women with ER+, HER2− metastatic breast cancer
